Careers Contact Overview Transactions News Our Team MTS HEALTH PARTNERS » NEWS SORT: All News | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 Sumitomo Dainippon Pharma and BehaVR announce landmark deal for multiple virtual reality digital therapeutics Published: October 18, 2021 Mnet Health Announces Acquisition of One Medical Passport, Inc. Published: October 5, 2021 Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals Published: September 30, 2021 Azurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceutical Published: August 24, 2021 Grifols signs an agreement with ImmunoTek to open 21 plasma centers and further advances on its expansion plan Published: July 30, 2021 Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc. Published: July 23, 2021 SERES THERAPEUTICS, NESTLÉ HEALTH SCIENCE ANNOUNCE SER-109 CO-COMMERCIALIZATION LICENSE AGREEMENT Published: July 1, 2021 Catalyst Pharmaceuticals Announces Exclusive License and Supply Agreement with DyDo Pharma for the Development and Commercialization of Firdapse® in Japan Published: June 28, 2021 MHH Healthcare, LLC to Acquire Medical Card System, Inc. (MCS), a Leading Healthcare Services Organization in Puerto Rico Published: June 14, 2021 Humana Announces Agreement to Acquire onehome Published: June 14, 2021 Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases Published: May 24, 2021 AGTC Announces Pricing of Public Offering of Common Stock and Warrants Published: February 1, 2021 Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At The Market” Offering Agreement Published: January 13, 2021 Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company Published: December 10, 2020 Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement Published: December 2, 2020 Press Ganey Advances Health Care Consumerism Movement with Acquisitions of Doctor.com and Majority Stake in Binary Fountain Published: October 16, 2020 Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares Published: September 16, 2020 MiNA Therapeutics Secures £23 Million Series A Financing to Advance First-inClass Activating RNA-Based Therapeutics Published: September 10, 2020 Verastem Oncology Signs Definitive Agreement to Sell COPIKTRA® (duvelisib) Rights to Secura Bio to Focus on Development of VS-6766 and Defactinib in KRAS Mutant Solid Tumors Published: August 25, 2020 Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program Published: August 10, 2020 SOC Telemed to Merge with Healthcare Merger Corp. Published: July 29, 2020 Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement Published: June 3, 2020 Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics Published: June 3, 2020 scPharmaceuticals Announces Pricing of Public Offering of Common Stock Published: May 20, 2020 Quorum Health Corporation Reaches Agreement with Majority of Lenders and Noteholders on Prepackaged Recapitalization Plan Published: April 7, 2020 Pager Announces $33M Financing Round Published: March 11, 2020 KabaFusion Acquires Lincare’s Infusion Pharmacies, Expanding Patient-Focused Home Infusion Services Nationwide Published: March 9, 2020 R1 Announces Agreement to Acquire SCI Solutions, a Leading Provider of Digital Patient Engagement Solutions Published: January 13, 2020 Bright Health to Expand into California through Planned Acquisition of Brand New Day Health Plan Published: January 8, 2020 Healthgrades Acquires Evariant Published: January 8, 2020 Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval Published: December 24, 2019 CareFirst BlueCross BlueShield Announces Agreements to Acquire Medicaid MCO Plans in Maryland and Washington, D.C. Published: December 20, 2019 Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement Published: December 19, 2019 Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis Published: November 25, 2019 Blue Cross Blue Shield Of Arizona To Serve AHCCCS-Eligible Arizonans With Purchase Of Steward Health Choice Arizona Published: November 8, 2019 Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance Published: October 31, 2019 GENESIS HEALTHCARE ENTERS INTO INVESTMENT TO BUY BACK REAL ESTATE HISTORICALLY LEASED Published: October 30, 2019 Lundbeck to acquire Alder BioPharmaceuticals – a company committed to transforming migraine treatment and prevention – in a transaction valued at up to USD 1.95 billion net of cash Published: September 17, 2019 Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc. Published: August 13, 2019 Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement Published: August 12, 2019 RECOMMENDED ACQUISITION OF AEGERION Published: June 10, 2019 Vical and Brickell Announce Merger Agreement Published: June 5, 2019 LifeArc monetises Keytruda® royalty interests to fund further research and investment Published: May 20, 2019 Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics | Acquisition Expected to be Completed by Mid-Year 2019 Published: May 20, 2019 Sagard Healthcare Royalty Partners and Newcastle University, UK Announce the Monetization of Royalty Interest in Cancer Drug, Rubraca Published: April 1, 2019 Paladina Health Acquires Activate Healthcare to Amplify Impact of Primary Care Nationwide Published: January 16, 2019 ImmunoGen Announces Sale of Residual Kadcyla Royalties Published: January 14, 2019 Tetra Discovery Partners and Shionogi & Co., Ltd. Collaborate on BPN14770 Development and Commercialization Published: December 20, 2018 Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin) Published: November 1, 2018 Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation Published: October 17, 2018 Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advance Digital Medicines for Mental Health Published: October 15, 2018 The MTS Biotech IPO Monitor – Edition 4: Q3 2018 Update – 2018 Looking to Beat the 2014 High Tide Mark For Biotech IPOs Published: October 4, 2018 The MTS Biotech Monitor – “Back to School” Edition Sept 2018 Update – Early-Stage IPO Performance: Phase I is the New Phase II Published: September 5, 2018 Poxel Expands Metabolic Pipeline Through Strategic Acquisition Agreement with DeuteRx for DRX-065, a Novel Clinical Stage Drug Candidate for NASH, and Other Programs Published: September 4, 2018 Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-based Drug Discovery, for Approximately $43 Million in Cash Published: August 9, 2018 Protalix BioTherapeutics Expands Partnership with Chiesi Farmaceutici to Include Exclusive U.S. Rights for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease Published: July 26, 2018 LifePoint Health to Merge with RCCH HealthCare Partners Published: July 23, 2018 The MTS Biotech IPO Monitor – Edition 3: H1 2018 Update – Will 2018 Beat the 2014 High Tide Mark For Biotech IPOs? Published: July 10, 2018 Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics LLC for Prialt Published: June 29, 2018 Akebia Therapeutics and Keryx Biopharmaceuticals to Merge, Creating a Fully Integrated Company Focused on the Development and Commercialization of Therapeutics for Patients with Kidney Disease Published: June 28, 2018 The MTS Biotech Monitor H1:2018 Preview – The Fourth Generation of Biotech IPOs Continues to Follow Moore’s Law – Avg GP $100M/Avg MC $400M is the New Avg GP $50M/Avg MC $200M Published: June 28, 2018 Barings Acquires Royalty Interest in Recombinant Therapy Vonvendi® From Boston Children’s Hospital Published: June 19, 2018 Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea Published: June 15, 2018 The MTS Biotech IPO Monitor – Edition 2: Q1 2018 Update – Signs of Nervousness Or Business as Usual? Published: April 19, 2018 Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases Published: April 17, 2018 Addex Sucessfully Raises CHF40 million in Capital Increase Published: April 3, 2018 pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company Will Rebrand as EyePoint Pharmaceuticals, Inc. Published: April 2, 2018 Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases Published: March 23, 2018 Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris Published: January 19, 2018 Kazuki Kusaka Joins MTS Health Partners as Partner Published: January 5, 2018 Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy Published: December 21, 2017 The MTS US Biotech IPO Monitor: 2017 Was a Banner Year – How Does This Bode For 2018, The 40th Birthday For The US Biotech IPO Market? Published: December 7, 2017 Charlie Ditkoff Joins MTS Health Partners as Senior Advisor Published: December 1, 2017 Gene Therapy – Near-term Revolution or Continued Evolution? Part 2: The Gene Therapy Ecosystem Published: November 16, 2017 David Low Joins MTS Health Partners as Partner Published: November 15, 2017 ImmusanT Raises $40 Million in Series C Financing Published: November 14, 2017 Mallinckrodt to Acquire Ocera Therapeutics and OCR-002, its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy Published: November 4, 2017 Aerie Pharmaceuticals Announces Drug Delivery Asset Acquisition to Further Advance Its Retinal Disease Program Published: October 12, 2017 Dimension Board Determines That Ultragenyx’s Unsolicited Proposal to Acquire Dimension for $6.00 Per Share Constitutes a “Superior Proposal” Published: October 2, 2017 Realm Therapeutics – Proposed Placing to raise £19.3 million Published: September 22, 2017 Strategic Advisory Analytics – Gene Therapy – Near-term Revolution or Continued Evolution? Part 1 Published: August 1, 2017 Anti-cancer treatment yields up to US$325M in landmark Australian deal Published: July 27, 2017 Physicians Dialysis Acquires Seven Dialysis Facilities in New Jersey and Texas Published: May 7, 2017 Zymeworks Announces Pricing of Initial Public Offering Published: April 27, 2017 Strategic Advisory Analytics – Series #2: Gene Therapy – Near-term Revolution or Continued Evolution? Published: April 26, 2017 Verona Pharma Announces Launch of Global Offering and Application to List on the NASDAQ Global Market Published: April 26, 2017 Feedback note 5 #complex drug pricing in 140 characters or less Published: March 24, 2017 Hitachi Chemical Signs Agreement to Purchase from Caladrius Biosciences the Remaining 80.1% Interest in PCT for $75 Million Published: March 16, 2017 Feedback #4 on Principled Drug Pricing Report: Orphan Drug Pricing – Unlikely to be Left Alone in the Current Drug Pricing Debate Published: March 10, 2017 Otsuka Pharmaceutical to Acquire Neurovance, Inc. Published: March 2, 2017 HonorHealth announces new cancer care network Published: February 1, 2017 Feedback 3 on Principled Drug Pricing Report: The frictional cost break-up in drug pricing – it’s not me, it’s you Published: January 26, 2017 Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid Published: January 18, 2017 Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals Published: January 8, 2017 OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement Published: January 5, 2017 Feedback 2 on Principled Drug Pricing Report: Unprincipled Price Rises – Where is the Value in an Unbearable Symptom? Published: January 5, 2017 RaNA Acquires Shire’s Industry Leading Messenger RNA Platform Published: January 4, 2017 Feedback 1 on Principled Drug Pricing Report: Will Drug Pricing Still Be as Big of an Issue Going Forward with the New Administration Published: December 7, 2016 WellCare to Acquire Universal American Corp. Published: November 17, 2016 Strategic Analytics Publishes Report on Drug Pricing: “Principled Drug Pricing Centered on Innovation and Choice: Part 1” Published: November 16, 2016 Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma Published: October 26, 2016 Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business Published: September 12, 2016 Dana-Farber Cancer Institute monetizes royalty interests derived from immunotherapy patents with Canada Pension Plan Investment Board Published: August 5, 2016 PathGroup Completes Recapitalization with Pritzker Group Private Capital Published: August 1, 2016 MRC Technology monetises royalties on cancer drug Keytruda® (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital Published: July 15, 2016 Verona Pharma plc Proposed Placing to raise c. £44.7 million (US$63.3 million) Published: June 17, 2016 William Stitt Joins MTS Health Partners as Partner Published: June 13, 2016 Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share Published: May 31, 2016 Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company Published: April 14, 2016 Unum announces agreement to acquire Louisiana-based Starmount Life Insurance Company Published: April 4, 2016 Celator Pharmaceuticals Closes $43.7 Million Underwritten Financing Published: March 29, 2016 Caladrius Biosciences Subsidiary PCT, LLC Enters Into Global Collaboration and License Agreement with Hitachi Chemical Published: March 14, 2016 Genesis HealthCare Signs Agreement To Sell Home Health And Hospice Operations Published: March 9, 2016 Aprecia Pharmaceuticals Set to Advance 3D Printed Drug Pipeline with Completion of $35 Million Financing Led by Deerfield Management Published: January 28, 2016 Acorda to Acquire Biotie Therapies Published: January 19, 2016 Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline of Azymetric™ Antibody Therapeutics Published: January 8, 2016 RestorGenex And Diffusion Pharmaceuticals Announce Merger Agreement Published: December 15, 2015 Raptor Pharmaceutical Corp. Expands Rare Disease Portfolio With the Acquisition of Quinsair(TM) Published: August 20, 2015 Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement Published: August 18, 2015 TeamHealth to Acquire IPC Healthcare for $1.6 Billion, Creating Leading Physician Services Organization Published: August 4, 2015 Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Agreement to Create Orphan Disease Company Focused on Complement C5 Inhibition Published: July 13, 2015 ARCA biopharma announces $37 million private placement Published: June 11, 2015 ImmunoGen, Inc. Announces $200 Million Non-Dilutive Royalty Transaction Published: March 30, 2015 TRACON Pharmaceuticals Announces Pricing of Initial Public Offering Published: January 29, 2015 Regado Biosciences and Tobira Therapeutics Announce Merger Agreement to Create Leading NASH Company Published: January 14, 2015 Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals Published: December 2, 2014 Acorda Therapeutics to Acquire Civitas Therapeutics Published: September 24, 2014 TRACON Pharmaceuticals Completes $27 Million Financing and Expands Management Team and Board of Directors Published: September 22, 2014 Aerie Announces $125 Million Convertible Notes Published: September 9, 2014 Skilled Healthcare To Combine With Genesis HealthCare In 100% Stock Transaction Published: August 18, 2014 Baxter Acquires AesRx, LLC, Including Its Investigational Sickle Cell Disease Treatment Published: July 9, 2014 Nicox to acquire Aciex Therapeutics, Inc. Published: July 2, 2014 Navigant Acquires Cymetrix, a Leading Healthcare Revenue Cycle Management Firm Published: May 14, 2014 Kaléo announces $150 million debt financing to support commercialization of EVZIO™ Published: April 11, 2014 Promise Healthcare Assumes Operations of Six Health Care Facilities Including Four Long-Term Acute Care Hospitals and Two Skilled Nursing Facilities Published: April 2, 2014 Oxygen Biotherapeutics Prices $52 Million Underwriten Offering Published: March 18, 2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by Teva Published: January 21, 2014 Iroko Pharmaceuticals Secures $75 Million in Debt Financing to Support ZORVOLEX™ (diclofenac) Commercialization Published: November 27, 2013 Almost Family, Inc. Signs Definitive Agreement to Acquire SunCrest HealthCare Published: November 5, 2013 Miraca Life Sciences Announces That It Has Acquired PLUS Diagnostics Published: October 24, 2013 La Jolla Pharmaceutical Company Announces Closing of $10 Million Financing and Capital Restructuring Published: October 1, 2013 Acorda Therapeutics Announces Acquisition of Two Neuropathic Pain Assets Published: July 9, 2013 University of Pennsylvania Sells a Portion of its Royalty Interest in Juxtapid® for $55 Million Published: June 25, 2013 RXI Pharmaceuticals Announces $16.4 Million Placement Of Common Stock Published: March 7, 2013 Amerihealth Agrees To Buy Chartered Health's Assets As Rehabilitator Seeks To Avoid Disruption In Medicaid Services Published: February 22, 2013 Arsenal Capital Partners Announces Recapitalization Investment In Tractmanager, Inc. Published: January 7, 2013 Bioscrip Enters Into Agreement To Acquire Homechoice Partners, Inc. Published: December 13, 2012 Genesis Healthcare Acquires Sun Healthcare Group, Inc. Published: December 3, 2012 Methylgene Closes Cdn.$26.1 Million Private Placement Published: November 21, 2012 Nupathe Announces Closing Of $28 Million Private Placement And Changes To Its Board Of Directors Published: October 23, 2012 Fibrocell Science, Inc. Announces $45 Million Private Placement And Enters Strategic Collaboration With Intrexon Published: October 8, 2012 Jazz Pharmaceuticals Enters Definitive Agreement To Sell Its Women's Health Business To Meda Published: September 6, 2012 Genesis Healthcare To Acquire Sun Healthcare Group, Inc. Published: June 20, 2012 Vince Lambert Joins MTS Health Partners As Senior Managing Director Published: June 19, 2012 Bioscrip Completes Sale Of Community Pharmacies And Centralized Specialty And Mail Service Pharmacy To Walgreens Published: May 7, 2012 Lumeris, Blues Plans Partner To Acquire Nation's Largest Real-time Health Care Communication Network Published: February 14, 2012 Bioscrip Sells Assets Of Specialty Pharmacies And Centralized Specialty And Mail Service Pharmacy To Walgreens Published: February 2, 2012 Kadmon Acquires First-in-class Ras Antagonist From Concordia Pharmaceuticals Published: January 9, 2012 Idenix Pharmaceuticals To Raise $61 Million In Follow On Public Offering Of Common Stock Published: November 16, 2011 A.P. Pharma To Raise $24 Million In Private Placement Of Common Stock And Warrants Published: June 29, 2011 Highmark And West Penn Allegheny Health System Announce Plans Published: June 28, 2011 Synageva Biopharma And Trimeris Announce Merger Agreement Published: June 13, 2011 Akorn Enters Into An Agreement To Acquire Advanced Vision Research Published: May 3, 2011 Methylgene Announces $34.5 Million Private Placement Published: March 24, 2011 Intercell Completes Placement Of Eur 33.0m Senior Convertible Debt Financing Published: February 23, 2011 Sun Healthcare Group, Inc. Announces The Acquisition Of Countryside Hospice Care, Inc.; Expands Solamor Hospice Operations Published: January 13, 2011 Acadia Pharmaceuticals Announces $15 Million Private Placement Published: January 11, 2011 Neurologix Completes Additional $7 Million Financing Published: December 6, 2010 Abbott And Reata Pharmaceuticals Announce Agreement To Develop And Commercialize Bardoxolone Methyl For Chronic Kidney Disease Outside The U.s. Published: September 23, 2010 Us Worldmeds Acquires Solstice Neurosciences Published: August 13, 2010 Sun Healthcare Group, Inc. Prices Public Offering Of 26,750,000 Million Shares Of Common Stock Published: August 13, 2010 Trubion Pharmaceuticals Announces Agreement To Be Acquired By Emergent Biosolutions Published: August 12, 2010 Nupathe Inc. Announces Pricing Of Initial Public Offering Published: August 6, 2010 Sun Healthcare Group, Inc. Announces Plan To Separate Its Operating And Real Property Assets; Adopts A Stockholder Rights Plan Published: May 24, 2010 Threshold Pharmaceuticals Completes $35 Million Private Equity Financing Published: October 6, 2009 Ligand To Acquire Neurogen For Stock And Contingent Value Rights Published: August 24, 2009 MTS Health Investors Acquires dna Diagnostics Center, Inc. Published: October 21, 2008 Threshold Pharmaceuticals Announces $18 Million Private Equity Financing Published: August 8, 2008 Threshold Pharmaceuticals Announces $18 Million Private Equity Financing Published: July 10, 2008 MTS Health Partners Announces Minority Investment By Funds Managed By Oaktree Published: January 15, 2008 MTS Health Partners Brings Two New Partners On Board Published: January 3, 2008 Apria Healthcare Signs Definitive Agreement To Acquire Coram, Inc. Published: October 12, 2007 Corporate Office 623 Fifth Avenue 14th Floor New York, NY 10022 P: (212) 887-2100 E: info@mtspartners.com About MTS Overview Our Team Transactions News Disclosures Business Continuity Disclosure Statement Privacy Policies Broker Check Membership FINRA SIPC Securities offered through MTS Securities, LLC. | MTS Securities, LLC is an affiliate of MTS Health Partners, L.P. | © 2021 MTS Health Partners, L.P. All rights reserved.